Home > Research > Browse

Results for Scleroderma, Systemic/drug therapy

Publications & Outputs

  1. A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's

    Tornling, G., Edenius, C., Pauling, J. D., Denton, C. P., Olsson, A., Kowalski, J., Murray, A., Anderson, M., Bhat, S., Del Galdo, F., Hall, F., Korkosz, M., Krasowska, D., Olas, J., Smith, V., van Laar, J. M., Vonk, M. C., Wojteczek, A. & Herrick, A. L., 1/02/2025, In: Rheumatology. 64, 2, p. 704-713 10 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review